Den europeiske union -
ungarsk -
EMA (European Medicines Agency)
adjupanrix (previously pandemic influenza vaccine (h5n1) (split virion, inactivated, adjuvanted) glaxosmithkline biologicals)
glaxosmithkline biologicals s.a. - inaktivált, antigént tartalmazó influenza vírus: a / vietnam / 1194/2004 (h5n1), mint a használt törzs (nibrg-14) - influenza, human; immunization; disease outbreaks - a vakcinák - az influenza profilaxisa a hivatalosan bejelentett pandémiás helyzetben. a pandémiás influenza vakcinát a hivatalos útmutatásnak megfelelően kell használni.
Den europeiske union -
spansk -
EMA (European Medicines Agency)
adjupanrix (previously pandemic influenza vaccine (h5n1) (split virion, inactivated, adjuvanted) glaxosmithkline biologicals)
glaxosmithkline biologicals s.a. - virus de la gripe dividido, inactivado, que contiene el antígeno: a / vietnam / 1194/2004 (h5n1) como la cepa utilizada (nibrg-14) - influenza, human; immunization; disease outbreaks - vacunas - profilaxis de la influenza en una situación de pandemia oficialmente declarada. la vacuna contra la influenza pandémica debe usarse de acuerdo con la guía oficial.
Den europeiske union -
engelsk -
EMA (European Medicines Agency)
eperzan
glaxosmithkline trading services limited - albiglutide - diabetes mellitus, type 2 - drugs used in diabetes - eperzan is indicated for the treatment of type 2 diabetes mellitus in adults to improve glycaemic control as:monotherapywhen diet and exercise alone do not provide adequate glycaemic control in patients for whom use of metformin is considered inappropriate due to contraindications or intolerance.add-on combination therapyin combination with other glucose-lowering medicinal products including basal insulin, when these, together with diet and exercise, do not provide adequate glycaemic control (see section 4.4 and 5.1 for available data on different combinations).
Italia -
italiensk -
Ministero della Salute
glaxosmithkline polident equilibrio 40g
glaxosmithkline c.health.spa -
Storbritannia -
engelsk -
MHRA (Medicines & Healthcare Products Regulatory Agency)
eperzan 30mg powder and solvent for solution for injection pre-filled pen
glaxosmithkline uk ltd - albiglutide - powder and solvent for solution for injection - 30mg
Storbritannia -
engelsk -
MHRA (Medicines & Healthcare Products Regulatory Agency)
eperzan 50mg powder and solvent for solution for injection pre-filled pen
glaxosmithkline uk ltd - albiglutide - powder and solvent for solution for injection - 50mg
Latvia -
latvisk -
Zāļu valsts aģentūra
tavegyl 1 mg/ml šķīdums injekcijām
glaxosmithkline dungarvan ltd., ireland - klemastīns - Šķīdums injekcijām - 1 mg/ml
Latvia -
latvisk -
Zāļu valsts aģentūra
fenistil 1 mg/1 ml pilieni iekšķīgai lietošanai, šķīdums
glaxosmithkline dungarvan ltd., ireland - dimetindēna maleāts - pilieni iekšķīgai lietošanai, šķīdums - 1 mg/ml
Latvia -
latvisk -
Zāļu valsts aģentūra
vibrocil 2,5 mg/0,25 mg/ml dozētais deguna aerosols
glaxosmithkline dungarvan ltd., ireland - phenylephrinum, dimetindeni maleas - deguna aerosols, šķīdums - 2,5 mg/0,25 mg/ml
Den europeiske union -
spansk -
EMA (European Medicines Agency)
trobalt
glaxo group limited - retigabina - epilepsia - los antiepilépticos, - trobalt está indicado como tratamiento adyuvante de convulsiones de inicio parcial resistente a los medicamentos con o sin generalización secundaria en pacientes mayores de 18 años o mayores con epilepsia, donde otras combinaciones de drogas adecuadas han demostrado ser insuficientes o no han sido tolerado.